Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Nasal Covid-19 Vaccine
Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022
Swarajya Staff
Sep 7, 2021 06:01 PM +05:30 IST
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic
Bhaswati Guha Majumder
May 4, 2021 01:25 PM +05:30 IST
Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna Ella
Swarajya Staff
Apr 25, 2021 12:31 PM +05:30 IST
Load More